Sort
82,697 grants matching “vaccine development”
Immunotherapeutic Approaches for AIDS
$1,436,310George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
SVEU - Reimmunization and Challenge Studies
$1,436,214Teri Saia · Bioqual, Inc. · N01 · FY2013 · AI
Development of a Practical Heroin-HIV Vaccine
$1,436,193Gary R. Matyas · Henry M. Jackson Fdn For The Adv Mil/Med · DP1 · FY2016 · DA
Studies of Central Nervous System Functional Anatomy
$1,435,998Miles A. Herkenham · National Institute Of Mental Health · ZIA · FY2016 · MH
NOVEL CELLULAR AND VIRAL TARGETS FOR ANTI-INFLUENZA VIRUS DRUGS
$1,435,679Peter Palese · Icahn School Of Medicine At Mount Sinai · U01 · FY2009 · AI
WASHINGTON UNIVERSITY AIDS CLINICAL TRIALS UNIT
$1,435,641David B Clifford · Washington University · U01 · FY2011 · AI
Laboratory And Pre-clinical Studies Of Parainfluenza Viruses
$1,435,433Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Cultivation, Nature, Ecology and Pathogenicity of the Uncultivable Oral Microbiom
$1,435,407Floyd E Dewhirst · Ada Forsyth Institute, Inc. · R01 · FY2016 · DE
Cultivation, Nature, Ecology and Pathogenicity of the Uncultivable Oral Microbiom
$1,435,407Floyd E Dewhirst · Ada Forsyth Institute, Inc. · R01 · FY2017 · DE
A Phase 1/2a, randomized study of a Tfh-targeting genetic vaccine adjuvant designed to induce broad, durable immune responses
$1,435,214Kara W Chew · University Of California Los Angeles · U01 · FY2024 · AI
Functional Genomics of Pathogenic Enterobacteriaceae
$1,434,869Anthony W Maresso · Baylor College Of Medicine · U19 · FY2024 · AI
Sample Collection and General Screening Protocols
$1,433,504Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Malaria Drug Resistance and Disease Virulence
$1,433,451Thomas E Wellems · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Primate Core
$1,432,772Roger A Van Andel · University Of New Mexico · P01 · FY2009 · AI
improving outcomes after stem cell transplantation
$1,432,613Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
Duke SPORE in Brain Cancer
$1,432,302John H Sampson · Duke University · P50 · FY2021 · CA
Maternal SARS-CoV-2 infection, placenta biology, and neurodevelopmental outcomes in the offspring
$1,431,755Gianluca Ursini · Lieber Institute, Inc. · R01 · FY2024 · HD
Industrialization Core: Production of monoclonal antibodies and product developm
$1,431,733Larry Zeitlin · Scripps Research Institute, The · U19 · FY2016 · AI
Task V30: GMP Manufacturing of WNV Vaccine
$1,430,843Wang Hong · Advanced Bioscience Laboratories, Inc. · N01 · FY2023 · AI
STAMPOUT: A Phase 2a Study of Antibody for Methamphetamine Outpatient Therapy
$1,429,307Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2019 · DA
Development of a Practical Heroin-HIV Vaccine
$1,428,939Gary R. Matyas · Henry M. Jackson Fdn For The Adv Mil/Med · DP1 · FY2015 · DA
Malaria Pathogenesis and Human Immunity
$1,428,771Rick Fairhurst · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
International Center for Excellence in Research (ICER) in Uganda: Impact of ARVs
$1,428,469Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Exploring mechanisms that govern immune homeostasis in skin
$1,428,279Keisuke Nagao · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Noroviruses and Epidemic Gastroenteritis
$1,428,257Kim Y. Green · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI